Mein Warenkorb

TGF-beta 1

TGF-beta 1 Molekülinformation

Englischer NameTransforming growth factor beta 1Anzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel22Target-AliasLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Höchste Forschungs- und EntwicklungsphaseApproved
Englischer NameTransforming growth factor beta 1
Target-AliasLatency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Anzahl der inverkehr gebrachten Arzneimittel1
Anzahl der klinischen Arzneimittel22
Höchste Forschungs- und EntwicklungsphaseApproved

TGF-beta 1 Molekülhintergrund

This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]

TGF-beta 1 Molekülalias

CEDLAP,TGF-beta 1,TGFB1,DPD1,TGF-beta-1,TGFB

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
VactosertibTEW-7197; EW-7197; NOV-1301Phase 3 ClinicalMedpacto IncAdenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Solid tumours; Stomach Neoplasms; Urologic Neoplasms
Details
Bintrafusp alfaM-7824; GSK-4045154; MSB-0011359CPhase 3 ClinicalMerck SeronoAnus Neoplasms; Biliary Tract Neoplasms; Brain metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Ganglioglioma; Head and Neck Neoplasms; Hematologic Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Microsatellite Instability; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Germ Cell and Embryonal; Nose Neoplasms; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Penile Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Respiratory papillomatosis; Sarcoma; Sarcoma, Kaposi; Skin Melanoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thymic epithelial tumor; Thymoma; Thymus Neoplasms; Triple Negative Breast Neop
Details
NisevokitugNIS-793Phase 3 ClinicalXoma CorpAdenocarcinoma; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Details
Yinfenidone HydrochlorideHEC-585; HEC-00000585Phase 3 ClinicalHec Pharm Co LtdIdiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis
Details
SB-01 (Ensol BioSciences)Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2KPhase 3 ClinicalEnsol Biosciences IncIntervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain
Details
LivmoniplimabMGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115Phase 3 ClinicalArgenx SeCarcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Solid tumours
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus IncCarcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
ZSP-1603ZSP-1603Phase 2 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co LtdCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms
Details
NicousamideXLF-III-43Phase 2 ClinicalInstitue Of Materia Medica Chinese Academy Of Medical ScienceDiabetic Nephropathies; Hypertensive nephropathy
Details
Meflonidone hydrochloridePhase 2 ClinicalCentral South University, Guangzhou Nanxin Pharma Co LtdDiabetes Mellitus, Type 2; Diabetic Nephropathies
Details
FluorofenidoneAKF-PDPhase 2 ClinicalCentral South University, Dierepharma HK Ltd, Hainan Haiyao Co LtdHepatitis B, Chronic; Liver Cirrhosis
Details
CotsiranibSTP-705LU; STP-705LV; STP-705; STP-705LPhase 2 ClinicalSirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co LtdCarcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cicatrix, Hypertrophic; Keloid; Liver Neoplasms; Obesity, Abdominal
Details
YL-13027YL-13027Phase 2 ClinicalYL-PharmaPancreatic Neoplasms; Solid tumours
Details
MR-001MR001; MR-001Phase 2 ClinicalShenzhen Maijiarui Biotechnology Co LtdCarcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
LinavonkibartSRK-181; SRT-BETA-1-AB3Phase 1 ClinicalScholar Rock IncNeoplasms
Details
Charis-1000Charis-1000; C 1K; C1KPhase 1 ClinicalEnsol Biosciences IncBreast Neoplasms
Details
HLX-6018HLX-6018; HLX6018Phase 1 ClinicalIdiopathic Pulmonary Fibrosis
Details
RO7496353RO7496353; RO-7496353; SOF 10; RG6440; RG-6440Phase 1 ClinicalGenentech IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours; Stomach Neoplasms
Details
JYB-1907JYB-1907Phase 1 ClinicalJiangxi Jemincare Group Co LtdSolid tumours
Details
STP-707STP-707; STP707Phase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co LtdCholangitis, Sclerosing; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
PXS-64PXS-64Phase 1 ClinicalSyntara LtdMultiple Sclerosis
Details
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics CorpPolycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Tonogenchoncel-LTG-CApprovedTissuegeneInvossa-K, InvossaSouth KoreaOsteoarthritisnull2017-07-01Intervertebral Disc Degeneration; Osteoarthritis; Osteoarthritis, Knee
Details

Produktrezensionen

  • 1***22019-10-12
    3Menschen mögen
    The TGFb1 protein was used as the negative comparing group in T-cell suppression experiments. The protein has a good bioactivity at suppressing T-cells by significantly inhibiting the proliferation of T-cells stimulated by anti-CD3. The repeatability and stability of the experiment was pretty good.
  • Molekülinformation
  • Produktliste
  • Inverkehr gebrachte Arzneimittelinformation
  • Produktrezensionen
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns